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Aim: Atherosclerosis is a common cardiovascular disease causing medical problems globally leading to
coronary artery bypass surgery. The present study is to fabricate core/shell nanofibers to encapsulate
VEGF for the differentiation of mesenchymal stem cells (MSCs) into smooth muscle cells to develop vascu-
lar grafts. Materials & methods: The fabricated core/shell nanofibers contained polycaprolactone/gelatin
as the shell, and silk fibroin/VEGF as the core materials. Results: The results observed that the core/shell
nanofibers interact to differentiate MSCs into smooth muscle cells by the expression of vascular smooth
muscle cell (VSMC) contractile proteins α-actinin, myosin and F-actin. Conclusion: The functionalized
polycaprolactone/gelatin/silk fibroin/VEGF (250 ng) core/shell nanofibers were fabricated for the con-
trolled release of VEGF in a persistent manner for the differentiation of MSCs into smooth muscle cells for
vascular tissue engineering.
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Atherosclerosis and coronary arterial restenosis are common cardiovascular diseases causing medical problems
globally. They require coronary artery bypass surgery where a blood vessel from the patient is explanted (autograft)
in the place of a diseased blood vessel to lead a normal blood flow around the obstructed area and recondition the flow
of blood to heart. Saphenous vein and native blood vessels (internal thoracic artery) are used to explant frequently
in last 12 years for coronary artery bypass or peripheral bypass surgery due to characteristic difference between
arteries and veins [1–3]. Synthetic vascular grafts are generally used for bypass surgery but it has several limitations
such as infection, weak patency in the case of small diameter graft due to accumulation of thrombus formation
on the lumen of the vessel and subsequently leads to failure of grafts [4,5]. The anatomy of blood vessels consists
of intima, media and adventitia, within the media lies the smooth muscles cells (SMCs), which provide structural
support to the vessels. Endothelial cells (ECs) cultured on vascular grafts have been proposed by many researchers;
however, isolation of ECs from the patients causes the structure of the blood vessel to be sacrificed. Human
mesenchymal stem cells (hMSCs) represent an alternative source of cells in the field of tissue engineering, which
has many advantages over ECs [6–7]. The first tissue-engineered blood vessel was developed in 1986 by Weinberg
and Bell using bovine ECs, SMCs and fibroblasts surrounded by collagen matrix [8]. Although, inappropriately,
this study was not succeeded, later this work was placed as a key base for expressing the vital elements to fabricate
tissue-engineered vascular graft (TEVG), and paved way in the field of vascular tissue engineering (VTE). Sultana et
al. (2017) fabricated electrospun polycaprolactone (PCL)/chitosan mats with smooth and bead-free fiber structure
to facilitate attachment and proliferation of ECs for the development of the inner layer of the blood vessel and
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SMCs for the formation of outer layer of artificial vascular grafts [9]. The fundamental elements of tissue engineering
are cells and scaffolds interaction for the secretion of extracellular matrix (ECM) to the formation of new tissues [10].
The biocomposite scaffolds thus developed to address the limitations such as inflammation, toxicity and recognition
due to the occurrence of scaffolds degradation [11–13]. Uchida et al. (2008) developed autologous TEVG, which
should not be recognized as foreign object, attuned immunologically and free from thrombus formation for the
regeneration of diseased blood vessels [14]. MSCs are one of the well-known sources in tissue engineering and have
remarkable functions in the field of regenerative medicine [15]. They have an ability to form abundant types of
tissues and organs, and can differentiate into multiple cell lineages [16,17]. MSCs cannot produce VEGF but VEGF
can induce the cells upon differentiation into vascular cell types by the expression of PDGF receptors, which is a
smooth muscle cell phenotypic modulator and angiogenic growth factor [18,19].
Electrospun nonwoven nanofibrous scaffolds are fabricated to mimic the function of native extracellular matrix
(ECM) in vascular tissue engineering [20–22]. Core/shell is a versatile technique that has interesting functionalities
over encapsulation of the active component, such as growth factors and drugs in core of fibers are beneficial in the
field of drug delivery and regenerative medicine [23,24]. PCL is the US FDA-approved synthetic polymer known for
its biodegradability, biocompatibility, permeability and good mechanical property [25–28]. Gelatin (GEL) is derived
from natural component collagen, possesses same properties as collagen providing native environment for VSMCs;
PCL is blended with GEL to obtain good mechanical stability for vascular grafts [29,30]. Fukunishi et al. (2016)
demonstrated the vascular SMCs maturation in an electrospun biodegradable PCL/chitosan TEVG in the sheep
model for engineering vascular grafts [31]. Silk fibroin (SF) is a fibrous protein, which tends to form a connective
tissue microstructure and has enormous properties in the field of biomedical such as biocompatibility, immune
response, permeability of water and oxygen for cell growth and chemical stability to mimic the in vivo environment
of ECM [32,33]. In vitro study proved that SF nanofibers support VTE by maintaining vascular cell phenotype
and backing the cell viability [34,35]. The present study is to develop functionalized core/shell nanofibers to mimic
native ECM for the differentiation of MSCs into SMCs for VTE, which could be developed into vascular grafts
beneficial for clinical perspective for bypass surgery in regenerative medicine.
Materials & methods
Materials
Polycaprolactone (MW 80,000), GEL from porcine skin type A (GEL strength ∼300 g Bloom), 1,1,1,3,3,3-
hexafluoro-2-propanol and 2,2,2-Trifluoroethanol were purchased from Sigma–Aldrich, Singapore; recombinant
human VEGF was purchased from Abcam (Singapore); Alexa Fluor 488 was purchased from Invitrogen, Singapore;
α-actinin and smooth muscle myosin were purchased from Abcam (Cambridge, MA, USA); Dulbecco’s modified
Eagle’s medium, fetal bovine serum, antibiotic–antimycotic solutions, trypsin–EDTA were purchased from Sigma–
Aldrich, Singapore; Alexa Fluor 647-Phalloidin was purchased from Molecular Probes by Life Technologies,
Singapore; and CellTracker CMFDA green was purchased from Promega, Singapore. SF powders were obtained
from Zhang Peng International Trading, Singapore; hMSCs from Lonza, Singapore.
Coaxial electrospinning for core/shell nanofibers
Coaxial electrospinning solutions of PCL/GEL were prepared separately at a 3:6 weight ratio, stirred overnight
at room temperature and separately prepared solutions were added together to obtain uniform solutions.
PCL/GEL/SF/VEGF core/shell nanofibers were prepared by dissolving 10% SF with VEGF (150 and 250 ng) as
core and PCL/GEL solution loaded as shell, which has weight percentage of 3 and 6% in 1,1,1,3,3,3-hexafluoro-
2-propanol. This process was performed using a 3 ml standard syringe, blunted 24-gauge needle, with the solution
flow rate maintained as core 0.75 ml/h and shell 1.5 ml/h, controlled using syringe pump (KDS 100, KD Scien-
tific, MA, USA). The distance between the needle tip and collector was set at 12–16 cm. A high voltage electric
field of 9–13 kV (DC high voltage power supply from Gamma High Voltage Research, FL, USA) was applied to
fabricate core/shell fibers from spinneret then collected on 15 mm coverslips placed over a grounded aluminium
foil collector. Subsequently, the fabricated core/shell nanofibers were vacuum dried to remove the residual solvents
present in the nanofibrous scaffolds. Quantitative analysis of VEGF release profile was performed in series of time
period (day 1–15) by the ELISA-Quantikine human VEGF kit by the instructions of manufacturer protocol (R&D
Systems, Novus Biologicals, Tocris Bioscience, MN, USA).
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Characterization of the core/shell nanofibers
Core/shell nanofibrous scaffolds were observed under Field emission scanning electron microscope (FE-SEM,
FEI-QUANTA 200F) for their surface morphology at 10 kV, followed by gold coating (JEOL JFC-1200 fine
coater, JEOL, Tokyo, Japan). Random fibers were selected from every scaffold as n = 25 for measuring fibers
diameter from the images of SEM. PCL/GEL/SF/VEGF core/shell nanofibers were observed by Transmission
electron microscopy (TEM), using a JEOL 2100 microscope at an accelerating voltage of 200 kV. The width of
fibers mentioned as diameter was calculated in average diameter alongside standard deviation by image analysis
software (ImageJ, NIH, MD, USA). Core/shell fibers were examined using Fourier transform infrared (FTIR)
spectroscopic analysis on Avatar 380, (Thermo Nicolet, MA, USA) for their functional group around the range of
500–4000 cm-1 at a resolution of 1 cm-1 and hydrophilic behavior of the nanofibers were analyzed under water
contact angle, using VCA Optima surface analysis system (AST products, MA, USA).
Culturing of hMSCs
MSCs were cultured in 75 cm2 flask with DMEM alongside 10% fetal bovine serum and 1% antibiotic–antimycotic
solutions and incubated at 37◦C on a humidified environment surrounding 5% CO2 for 5 days and every alternative
day changed the complete medium. The cells grown in 75 cm2 cell culture flasks were trypsinized by adding 1 ml
of 0.25% trypsin containing 0.1% EDTA to lift cells in the flasks and then centrifuged for collecting cells. Trypan
blue assay used to count the cells in hemocytometer and then cells were seeded onto the scaffolds at a seeding
density of 10,000 cells per well. Cells seeded on Tissue culture plate (TCP) were used as a control to monitor the
morphology, growth and differentiation of cells.
Cell proliferation
Cell proliferation was analyzed in PCL/GEL, PCL/GEL/SF, PCL/GEL/SF/VEGF (150 & 250 ng) and TCP
core/shell nanofibrous scaffolds by MTS assay (CellTiter 96 AQueous Assay) for a period of 5, 10 and 15 days. The
core/shell nanofibers were sterilized by treating UV light for 3 h. The sterilized fibers were placed in 24-well plate
with stainless steel rings, in order to avoid lifting of fibers upwards followed by washing in phosphate-buffered saline
(PBS) to remove the residual solvents consequently; the fibers were then kept overnight in DMEM before seeding
cells. After culturing cells on nanofibers (10,000 cells/well), the cells were washed with PBS to remove the dead
and unattached cells subsequently then MTS reagent (1:4) in serum-free media was added followed by incubation
for 3 h in the incubator, which maintains 37◦C in 5% CO2. After addition of MTS reagent, formation of purple
formazan crystals was observed, which results in reduction of tetrazolium salt by dehydrogenase enzymes secreted
by mitochondria of metabolically active cells. The dye obtained thereby was transferred to 96-well plate to measure
at 490 nm, using a spectrophotometric plate reader (FLUOstar OPTIMA, BMG Lab Technologies, Ortenberg,
Germany). Intensity of formazan dye found is directly proportional to the number of cells.
Cell morphology
FE-SEM (FEI-QUANTA 200F) was used to determine the morphology of cells for the day 10. Cell culture medium
was removed from the cells scaffolds and washed with PBS two times. Subsequently, the cells were fixed with 3%
glutaraldehyde in cold PBS for 3 h. The scaffolds were washed with distilled water for 15 min and dehydrated
with a series of ethanol gradients starting from 30, 50, 75, 90 to 100% (v/v) followed by treating the samples
with hexamethyldisilazane (HMDS) solution and allowed to air-dry at room temperature in the fume hood. The
samples were then removed and coated with gold and analyzed in FE-SEM.
Expression of 5-chloromethyl-fluorescein-diacetate dye
Cultured cells were stained with green fluorescent dye 5-chloromethyl-fluorescein-diacetate (CMFDA) to track the
live cells. CMFDA dye passes the live cell membrane and transforms into the cell membrane as an impermanent
reaction, which results in monitoring live cells. Before adding the fluorescent dye to scaffold-containing cells,
medium should be removed by the addition of CMFDA dye with serum-free DMEM at a concentration of 20 μl
(25 μM)/180 μl and incubated at 37◦C for 3 h in an incubator. Subsequently, the CMFDA dye should be removed
and replaced by the complete DMEM to incubate at 37◦C for 24 h. After a day, the medium was removed from
the scaffold-containing cells then washed with PBS to remove the dye and dead cells. Serum-free media of 200 μl
added to the scaffolds, which was observed under an inverted Leica DM IRB laser-scanning microscope, Wetzlar,
Germany (Leica DC 300F) at 488 nm.
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Expression of collagen
Sirius red staining (0.1%) was performed to determine the secretion of collagen in the cell matrix qualitatively.
Initially, the cells were washed with PBS, fixed in 10% formaldehyde, and then 200 μl of hematoxylin was added
to incubate for 1 h. Followed by washing with deionized water thrice, the cell scaffolds were stained with Sirius red
for 1 h and subsequently washed with mild acidified water to remove unbounded dye to capture images. Finally,
the expression of collagen stained red on a yellow background in the nanofibrous scaffolds was viewed under Leica
DM IRB microscope.
Immunofluorescence analysis by Confocal laser scanning microscope (CLSM)
Expression of α-actinin & myosin
Expression of contractile-specific marker protein was observed on the differentiated cells cultured on the nanofibrous
scaffolds. For CLSM analysis, on day 15, the cells were fixed with 100% ice-cold methanol before processing. The
samples were then washed with PBS once for 15 min and incubated in 0.5% Triton-X solution (Sigma–Aldrich,
Singapore) in order to make the cell membrane permeable; the nonspecific binding sites were blocked by adding
3% bovine serum albumin (BSA), for 1 h. Subsequently, the primary antibodies α-actinin and myosin heavy chain
were added in a dilution of 1:100 for 90 min at room temperature. Later the samples were washed with PBS for
15 min to remove the excess unbound primary antibodies. This was followed by incubation with Alexa Fluor 488
secondary antibodies in a dilution of 1:250 for 60 min at room temperature. The samples were washed with PBS
for 15 min and stained with diamidino-2-phenylindole dihydrochloride (DAPI – 1:2000 dilution) for 30 min at
room temperature. The cells were again washed with PBS, then the samples were removed and mounted over glass
slides using Vectashield mounting medium (Sigma–Aldrich, Singapore) and observed under Olympus FV1000
CLSM (Olympus Singapore Pte Ltd, Singapore).
F-actin
Cells seeded on core/shell nanofibrous scaffolds were stained for the expression of F-actin on day 15 of cell culture.
Cells fixed with ice cold methanol, were washed with PBS and incubated with 0.5% Triton-X100 to make the cell
membrane permeable for 5 min. Upon addition of 3% BSA, which blocks the nonspecific sites, the samples were
added with Alexa Fluor 647-Phalloidin and incubated for 90 min at room temperature in the dilution of 1:100.
The samples were incubated with DAPI dilution of 1:2000 for 30 min followed by washing in PBS to remove the
excess staining. The samples were mounted in glass slide with the help of mounting medium and examined under
Olympus FV1000-CLSM.
Statistical analysis
Experimental data were presented as mean standard deviation (n = 6). Statistical differences between the groups were
analyzed using one-way analysis of variance using Tukey’s post-hoc analysis. Statistical significance was represented
as *p < 0.05, **p < 0.01 and ***p < 0.001.
Results
Characterization of core/shell nanofibers
Core/shell nanofibers fabricated to mimic the native ECM for the differentiation of MSCs into VSMCs for the re-
generation of vascular tissues.Figure 1 shows the morphology of PCL/GEL, PCL/GEL/SF, PCL/GEL/SF/VEGF
(150 ng) and PCL/GEL/SF/VEGF (250 ng) core/shell nanofibers. The fiber diameter obtained in the range
of 753 ± 44 for PCL/GEL, 656 ± 52 for PCL/GEL/SF, 478 ± 70 for PCL/GEL/SF/VEGF (150 ng) and
454 ± 68 nm for PCL/GEL/SF/VEGF (250 ng). The TEM image is showing the double layer of core and
shell separately for PCL/GEL/SF/VEGF nanofibers (Figure 1F). The water contact angle of nanofibrous scaf-
folds observed PCL/GEL approximately 56.6 ± 7.1◦, PCL/GEL/SF ∼ 36.2 ± 4.3◦, PCL/GEL/SF/VEGF
(150 ng) ∼46.5 ± 5.1◦ and PCL/GEL/SF/VEGF (250 ng) ∼44.7 ± 4.7◦ (Table 1).Figure 2 shows PCL/GEL,
PCL/GEL/SF, PCL/GEL/SF/VEGF (150 ng) and PCL/GEL/SF/VEGF (250 ng) of coaxial electrospinning
nanofibers have tensile strengths of approximately 3.0, 3.3, 2.8 and 2.6 MPa (Megapascal). FTIR results show the
characteristic peaks of PCL, GEL, SF and VEGF (Figure 3). The peaks at 3295 and 1636 cm-1 were observed
as N-H stretching and C = O amide bond stretching for GEL, respectively. C = O ester stretching vibration as a
prominent peak at 1725 cm-1 (saturated aldehyde) was observed in all nanofibrous scaffolds, which confirms the
presence of PCL. FTIR spectrum shows the important functional groups such as amine 1, 2 and 3 in infrared (IR)
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SEI 10.0 kv 10 µm× 2500 WD 7.4 mm
SEI 10.0 kv 10 µm× 2500 WD 7.4 mm SEI 10.0 kv 10 µm× 2500 WD 7.4 mm SEI 10.0 kv
200 nm
10 µm× 2500 WD 7.4 mm
Figure 1. Scanning electron microscopy images of biocomposite functionalized core/shell nanofibers. (A) PCL/GEL, (B) PCL/GEL/SF, (C)
PCL/GEL/SF/VEGF (150 ng), (D) PCL/GEL/SF/VEGF (250 ng) and (E) fluorescein isothiocyanate fluorescent image. (F) Transmission electron
microscopy image of core/shell nanofibers.
GEL: Gelatin; PCL: Polycaprolactone; SF: Silk fibroin.
Table 1. Characterization of functionalized core/shell nanofibers for contact angle, fiber diameter, tensile stress and
Young’s modulus.
Core/shell nanofibers Fiber diameter (nm) Water contact angle (◦) Tensile stress (MPa) Young’s modulus (MPa)
PCL/GEL 753 ± 44 56.6 ± 7.1 3.0 30.2
PCL/GEL/SF 656 ± 52 36.2 ± 4.3 3.3 33.7
PCL/GEL/SF/VEGF
150 ng
478 ± 70 46.5 ± 5.1 2.8 34.9
PCL/GEL/SF/VEGF
250 ng
454 ± 68 44.7 ± 4.7 2.6 32.4
GEL: Gelatin; MPa: Megapascal; PCL: Polycaprolactone; SF: Silk fibroin.
peaks as bending vibration 1636 and 1537 (NH2), and C-N stretching 1240 cm-1 respectively, in scaffolds loaded
with SF. The cumulative VEGF release profile was detected initially very low on day 2, later growth factor release
was significantly increased after day 10 for initiating the cell differentiation leads to SMCs (Supplementary Figure
1).
Biological activity of cells
The proliferation of cells in PCL/GEL, PCL/GEL/SF, PCL/GEL/SF/VEGF (150 ng) and PCL/GEL/SF/VEGF
(250 ng) nanofibers was monitored for a time period of days 5, 10 and 15 to prove the scaffolds that were not cytotoxic
for culturing of cells (Figure 4). Initially on day 5, PCL/GEL/SF/VEGF (150 ng) and PCL/GEL/SF/VEGF
(250 ng) were showing normal cell proliferation rate similar to that of PCL/GEL/SF nanofibers. Subsequently, on
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Figure 2. Tensile properties of PCL/GEL, PCL/GEL/SF, PCL/GEL/SF/VEGF (150 ng) and PCL/GEL/SF/VEGF (250
ng) functionalized core/shell nanofibrous scaffolds.
GEL: Gelatin; PCL: Polycaprolactone; SF: Silk fibroin.
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Figure 3. Fourier transform infrared spectra of functionalized biocomposite core/shell nanofibrous scaffolds. (A)
PCL/GEL, (B) PCL/GEL/SF and (C) PCL/GEL/SF/VEGF (250 ng).
GEL: Gelatin; PCL: Polycaprolactone; SF: Silk fibroin.
day 10 decreased cell proliferation was observed in PCL/GEL/SF/VEGF 150 ng (5%) and PCL/GEL/SF/VEGF
250 ng (12.6%) compared with PCL/GEL/SF scaffolds and also on day 15, scaffolds were loaded with VEGF 150 ng
(14.35%) and 250 ng (16%). Fluorescent imaging was captured on the cells seeded nanofibrous scaffolds under the
influence of CMFDA dye. CMFDA fluorescence dye penetrates through cell membrane of viable cells, where it is
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Figure 4. Proliferation of mesenchymal stem cells on
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(250 ng) functionalized biocomposite core/shell
nanofibrous scaffolds. Data are presented as
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< 0.01, ***p < 0.001).
GEL: Gelatin; PCL: Polycaprolactone; SF: Silk fibroin.
Figure 5. The 5-chloromethyl-fluorescein-diacetate dye for live cell imaging on functionalized biocomposite
core/shell nanofibrous scaffolds on day 10. (A) Tissue culture plate, (B) PCL/GEL,
(C) PCL/GEL/SF, (D) PCL/GEL/SF/VEGF (150 ng), and (E) PCL/GEL/SF/VEGF (250 ng), scale bar = 50 μm.
GEL: Gelatin; PCL: Polycaprolactone; SF: Silk fibroin.
changed into cells impermeant and exhibits a fluorescence acting upon cystolic esterase in cells within 60 min. The
cells tagged with chloromethyl derivative of CMFDA respond with polypeptide that carries thiols, which leads to
bright fluorescence expressed in viable cells. Figure 5 displays the CMFDA dye expression in hMSCs cultured on
TCP and all other core/shell nanofibrous scaffolds. Sirius red staining was used to analyze the secretion of collagen
in cells cultured on core/shell nanofibers, higher level of collagen secretion was observed in PCL/GEL/SF/VEGF
250 ng nanofibers compared with all other nanofibrous scaffolds (Figure 6). Generally, morphology of the cells
in response to biomolecules present in the nanofibrous scaffolds, the cells–scaffold interaction depends on cell
adhesion, proliferation, migration and differentiation leads to develop vascular grafts (Figure 7). The results
showed that vascular proteins such as α-actinin, myosin and F-actin are expressed in differentiated MSCs cultured
on PCL/GEL, PCL/GEL/SF, PCL/GEL/SF/VEGF (150 ng) and PCL/GEL/SF/VEGF (250 ng) core/shell
nanofibrous scaffolds for the regeneration of vascular tissues (Figure 8).
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Figure 6. Sirius red staining for collagen expression on day 10. (A) Tissue culture plate (B) PCL/GEL, (C) PCL/GEL/SF,
(D) PCL/GEL/SF/VEGF (150 ng), and (E) PCL/GEL/SF/VEGF (250 ng) core/shell nanofibers, scale bar = 50 μm.
GEL: Gelatin PCL: Polycaprolactone; SF: Silk fibroin.
SEI 10 µm10.0 kV x1000 WD 6.5 mm
SEI 10 µm10.0 kV x1000 WD 6.5 mm SEI 10 µm10.0 kV x1000 WD 6.5 mm
SEI 10 µm10.0 kV x1000 WD 6.5 mm SEI 10 µm10.0 kV x1000 WD 6.5 mm
Figure 7. Morphology of the mesenchymal stem cells cultured on the functionalized biocomposite core/shell
nanofibrous scaffolds on day 10. (A) TCP, (B) PCL/GEL, (C) PCL/GEL/SF, (D) PCL/GEL/SF/VEGF (150 ng), and (E)
PCL/GEL/SF/VEGF (250 ng).
GEL: Gelatin; PCL: Polycaprolactone; SF: Silk fibroin.
Discussion
Characterization of core/shell nanofibers
Core/shell nanofibers fabricated in nanoscale dimension by synthetic and natural polymers, which is biodegradable
in nature to mimic the natural ECM with high porosity, well interconnected pores and large surface area for better
ingrowth of cells for tissue engineering applications. The fiber diameter of PCL/GEL nanofibers was obtained
753 ± 44 nm, which decreases in the presence of SF (PCL/GEL/SF ∼ 656 ± 52 nm), further decreased upon
incorporation of VEGF (PCL/GEL/SF/VEGF [150 ng] ∼ 478 ± 70 nm; PCL/GEL/SF/VEGF [250 ng] ∼
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Figure 8. Immunofluorescence analysis of human mesenchymal stem cells. (A–E) Expression of VSMCs-specific marker protein α-actinin
(green) on day 15, (F, G, H, I, J) smooth muscle myosin (red), and (K, L, M, N, O) phalloidin for expression of F-actin on tissue culture plate
(A, F, K), PCL/GEL (B, G, L), PCL/GEL/SF (C, H, M), PCL/GEL/SF/VEGF (150 ng) (D, I, N), PCL/GEL/SF/VEGF (250 ng) (E, J, O), nucleus stained
with DAPI (blue), scale bar = 20 μm.
GEL: Gelatin; PCL: Polycaprolactone; VSMC: Vascular smooth muscle cell; SF: Silk fibroin.
454 ± 68 nm; Figure 1). This decrement could be assigned to increase in conductivity of the solution with SF and
VEGF. The decrease in fiber diameter containing VEGF was also proved by Tian et al. [36]. Natural and synthetic
polymers were blended for the surface modification of core/shell nanofibers, which influence cell adhesion and
proliferation by the impact of functional groups such as hydroxyl, amine and carboxylic group. The hydrophilicities
measured on the nanofibrous scaffolds were PCL/GEL approximately 56.6 ± 7.1◦, PCL/GEL/SF∼36.2 ± 4.3◦,
PCL/GEL/SF/VEGF (150 ng)∼46.5 ± 5.1◦ and PCL/GEL/SF/VEGF (250 ng) ∼44.7 ± 4.7◦ (Table 1).
Generally observed that all scaffolds have contact angle <90◦, which is favorable for cell adhesion and proliferation
in vascular tissue engineering.
Core/shell formation evaluation, a control experiment was done using FITC–BSA system as core and PCL/GEL
as shell; Figure 1E shows emission of fluorescent light in the presence of FITC, thereby conforming the
core/shell formation. The control experiment clearly demonstrated the distribution of growth factor (protein)
in the core of PCL/GEL/SF/VEGF nanofibers. PCL/GEL, PCL/GEL/SF, PCL/GEL/SF/VEGF (150 ng) and
PCL/GEL/SF/VEGF (250 ng) of coaxial electrospinning nanofibers have tensile strengths approximately 3.0,
3.3, 2.8 and 2.6 MPa (Figure 2 & Table 1). Tensile strength of the nanofiber scaffolds loaded with silk fibroin
has increased in comparison with scaffolds without PCL/GEL fibers; the increase in mechanical property is due
to high-density ratio of silk fibroin and β sheet, which help to form a polymer network by crosslinking fibroins
together [37]. Mrówczyński et al. (2014) proved that the biodegradable, electrospun PCL grafts showed good surgical
and mechanical properties, endothelialization, no aneurysm formation, and similar short-term patency compared
with poly(tetrafluoroethylene) (ePTFE) grafts [38]. Results observed that VEGF added into PCL/GEL/SF decreased
mechanical strength of PCL/GEL/SF/VEGF (150 ng) to 2.8 MPa, PCL/GEL/SF/VEGF (250 ng) to 2.6 MPa
compared with PCL/GEL and PCL/GEL/SF nanofibers. Kai et al. (2015) demonstrated similar results of lower
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mechanical property in nanofibers by incorporation of VEGF [39]. Human coronary artery has tensile stress of
1.4 MPa [40]. FTIR spectrum shows in Figure 3, the saturated aldehyde peak at 1725 cm-1 and specific functional
groups such as amine 1, 2 and 3 in IR peaks as bending vibration 1636 and 1537 (NH2), and C-N stretching
1240 cm-1 respectively, in PCL fibrous scaffolds loaded with SF [41,42]. VEGF and SF proteins share same surface
functional moieties such as amine (NH) and carboxylic group (COOH), and its characteristic peaks may have
diffused with that of SF. General protein band displays at 1636 cm-1 (amine 1) and 1537 cm-1 (amine 2) conforming
the stretching vibration of C = O, C-N to bending vibration of N-H in functionalized core/shell nanofibers.
Biological characterization in vitro
Cell proliferation
Proliferation of cells was monitored for a series of time periods 5, 10 and 15 days (Figure 4). Initially on day 5,
PCL/GEL/SF/VEGF (150 ng) and PCL/GEL/SF/VEGF (250 ng) were showing normal cell proliferation rate
similar to that of PCL/GEL/SF nanofibers. The cell proliferation was decreased in PCL/GEL/SF/VEGF 150 ng
(5%) and PCL/GEL/SF/VEGF 250 ng (12.6%) compared with PCL/GEL/SF core/shell nanofibers on day 10;
and also on day 15, core/shell nanofibers were loaded with VEGF 150 ng (14.35%) and 250 ng (16%) %).
Ravichandran et al. (2013) reported that the rate of proliferation of cells begins to decrease while differentiation of
stem cells due to withdrawal of cell cycle and become terminally differentiated cells [43]. The results also obtained
for VEGF-loaded nanofibrous scaffolds on day 15 show decrease in proliferation due to the differentiation of
hMSCs to VSMCs. PCL/GEL/SF nanofibers display higher proliferation compared with PCL/GEL, which is due
to the influence of SF, the natural compound helps cells to attach and grow better by supporting cell viability and
maintaining normal cell phenotype [44,45].
Expression of 5-chloromethyl-fluorescein-diacetate
CMFDA is cell-tracker dye, provides sharp fluorescence that differentiate among cells and nanofibers, which helps
to observe the size, shape and morphology of viable cells in vitro. Figure 5 displays the CMFDA dye expression in
hMSCs cultured on TCP and all other core/shell-functionalized nanofibrous scaffolds. A clear difference in cell
morphology was observed in scaffolds with and without VEGF. VEGF loaded core/shell fibers showing well-aligned
elongated spindle shaped cells with notable cell to cell interaction within the cells scaffolds. The PCL/GEL and
PCL/GEL/SF, without VEGF display irregular spherical shaped cells with notable cell to cell interactions due to
the presence of biopolymers. Subsequently, the cells in PCL/GEL/SF/VEGF 250 ng (Figure 5E) showed more
MSCs differentiated into elongated spindle-shaped SMCs-like morphology with good interconnection of cells
and well-supported growth along the surface of core/shell fibrous scaffolds compared with all other nanofibrous
scaffolds.
Secretion of collagen
Picro-Sirius red staining is the marker for qualitative analysis of collagen to confirm the secretion of ECM in cells
cultured on the core/shell nanofibrous scaffolds. Sulfonic acid group of anionic dye from Picro-Sirius red interacts
with the basic groups of collagen, which tend to show the stained red color. Collagen is a specific protein, highly
responsible for the strength and elasticity of any skin coverings and is one of the major ECM. Collagen secretion
was notably observed in all samples after day 10. Subsequently, Figure 6E (PCL/GEL/SF/VEGF 250 ng) observed
higher levels of collagen secretion compared with all other nanofibrous scaffolds. It becomes apparent that the cells
secretion of collagen in biocomposite nanofibrous scaffolds are likely to initiate blood vessel tissue regeneration.
Morphology of cells in core/shell nanofibers
Figure 7 shows the interaction of cells-scaffolds progression of appropriate biological responses such as adhesion, cell
morphology, growth, migration and differentiation of cells by core/shell nanofibers fabricated with biocompatible
natural polymers and growth factors. Hybridization of PCL and GEL provides a better rough surface for cell binding
site and good mechanical property for nanofibers. PCL lacks the hydrophilic nature, which is significant for cell
communication; GEL does not exhibit good mechanical properties. VEGF-loaded PCL/GEL/SF nanofibers were
chosen to observe the VSMCs differentiation from hMSCs that further leads to the formation of vascular grafts.
PCL/GEL and PCL/GEL/SF shows better adhesion and growth of cells compared with TCP due to more number
of protein binding sites provided by SF and GEL on day 10. PCL/GEL and PCL/GEL/SF observed that the cells
penetrated into nanofibrous scaffolds through enhanced migration and cellular communication; thereby proving the
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biological advantages of nanofibers. Cells in PCL/GEL/SF/VEGF (150 ng) and PCL/GEL/SF/VEGF (250 ng)
nanofibers showed that cells were well aligned, interconnected with spindle-shaped cells and elongated VSMCs
phenotypic morphology observed in the differentiated cells. Density of cells in PCL/GEL/SF/VEGF (150 ng)
and PCL/GEL/SF/VEGF (250 ng) was low compared with PCL/GEL and PCL/GEL/SF, which is due to the
differentiation induced by bioactive VEGF incorporated with SF core/shell nanofibers.
VSMCs marker proteins
During the stage of vascular diseases, smooth muscle cells of the blood vessel lose their contractile proteins and
increased their proliferation, migration and secretion of ECM proteins. VSMCs remain very particular to maintain
the functions of contraction and help to control the blood flow and blood pressure. Contractile proteins of SMCs
play a major role in the development of blood vessels, also regulate the diameter of blood vessel during blood
flow. In order to witness the differentiation of hMSCs into VSMCs, the immunofluorescence-specific marker
proteins are analyzed, which are significant for contractile properties of SMCs [46]. VSMCs express the cytoskeletal
proteins, myosin and α-actinin, to maintain the cell phenotypes [47]. The observed results showed more or less
similar to the differentiation of MSCs into the contraction and dilatation properties of SMCs as proved by Sultana
et al. (2017) in vascular tissue engineering [9]. Figure 8 shows the expression of actinin and myosin filament on
the core/shell nanofibers is obvious compared with TCP, which means immunofluorescent labeling shows greater
amount of actinin and myosin expression in core/shell nanofibers. The results show that hMSCs cultured on
PCL/GEL/SF/VEGF (150 ng) and PCL/GEL/SF/VEGF (250 ng) have experienced complete differentiation
by controlled release of VEGF in core/shell nanofibers and it is evident from their morphology of VSMCs and
expression of marker proteins. The expression of contractile proteins, α-actinin and myosin, was low in PCL/GEL
and PCL/GEL/SF while in PCL/GEL/SF/VEGF (150 ng) and PCL/GE/SF/VEGF (250 ng) obtained higher
levels of proteins for proving the differentiation of MSCs into vascular tissue engineering (Figure 8).
Phalloidin stains the filaments of actin, which is expressed in cells by binding of actin in the polymerized form.
F-actin is one of the significant proteins for all cell types including VSMCs and also plays an important role in
cell contraction that helps to bear the stress of blood flow by actin filaments. Zhou et al. (2016) demonstrated
that the two-layered bioengineered vessels (PCL/GEL) exhibited biomechanical properties similar to normal
human saphenous veins and also to differentiate the human adipose-derived stem cells differentiated into SMCs
and ECs for bioengineering small-diameter blood vessels [48]. The observed results of PCL/GEL/SF/VEGF
(150 ng) show higher level of F-actin expression than PCL/GEL, PCL/GEL/SF and TCP. Subsequently, in
Figure 8J, PCL/GEL/SF/VEGF (250 ng) shows more expression of F-actin in comparison to all other core/shell
nanofibrous scaffolds. The results proved that the PCL/GEL/SF/VEGF (250 ng) and 150 ng functionalized
core/shell nanofibrous scaffolds induced the differentiation of MSCs into spindle-shaped VSMCs with increased
expression of specific marker proteins, thereby evidencing the regeneration of vascular tissue in regenerative
medicine.
Conclusion
Coaxial electrospinning process used to fabricate PCL/GEL, PCL/GEL/SF, PCL/GEL/SF/VEGF (150 ng)
and PCL/GEL/SF/VEGF (250 ng) functionalized core/shell nanofibers. These core/shell nanofibers supported
the cell growth in case of cell adhesion, migration and proliferation by inducing suitable environment alike
native ECM for vascular tissue engineering. It was shown by contact angle measurements that the nanofibrous
scaffolds containing VEGF exhibited significantly higher surface hydrophilicity compared with PCL/GEL and
PCL/GEL/SF nanofibers. Core/shell nanofibrous scaffolds containing growth factor (VEGF) showed a prominent
change in morphology and proliferation of cells by inducing the therapeutic angiogenesis by VEGF. The scaffolds
with SF, which has a wide range of vascular tissue engineering potential as effective property over drug release and
good mechanical property, incorporated with VEGF show low proliferation rate by means of differentiation of the
hMSCs to VSMCs. These studies demonstrated that functionalized core/shell nanofibers loaded with VEGF have
good potential for the regeneration of new tissue by its bioactivity. The bioactive PCL/GEL/SF/VEGF (250 ng)
core/shell nanofibrous scaffolds fabricated by coaxial electrospinning based on silk fibroin make them efficient for
controlled releasing VEGF in a persistent manner and widely favorable scaffolds in vascular tissue engineering.
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Future perspective
Atherosclerosis and coronary arterial restenosis are common cardiovascular diseases causing medical problems
globally, which demand coronary artery bypass surgery. The surgical bypass grafting mostly involves the use of
autologous vessels, such as the saphenous vein and internal thoracic artery. Synthetic vascular graft is an alternative
to the natural conduits, but it has several limitations such as infection, weak patency in the case of small diameter
vascular graft due to an accumulation of thrombus in the lumen of the vessel and subsequently leads to the failure of
grafts. The functionalized core/shell nanofibers supported cell growth, migration, proliferation and differentiation
by inducing suitable environment alike native ECM for developing vascular grafts. The drawback using synthetic
grafts is to resolve the problem, we developed functionalized core/shell nanofibers grafts play a role in the controlled
delivery of growth factors to initiate the differentiation of mesenchymal stem cells into vascular smooth muscle
cells to develop vascular grafts more beneficial for clinical perspective for bypass surgery in regenerative medicine.
Summary points
• Coaxial electrospinning technique used for the fabrication of core/shell nanofibers contained
polycaprolactone/gelatin (PCL/GEL) as the shell, and silk fibroin (SF)/VEGF (150 & 250 ng) as the core materials.
• The core/shell fiber diameter increased in PCL/GEL nanofibers, which was decreased significantly in SF/VEGF
nanofibers by increasing the conductivity of the solution.
• VEGF-loaded core/shell nanofibrous scaffolds observed decreased in cells proliferation compared with
PCL/GEL/SF nanofibers due to the differentiation of human mesenchymal stem cells to VSMCs.
• Mesenchymal stem cells cultured on PCL/GEL/SF/VEGF (250 ng) showed differentiation of smooth muscles cells by
the controlled release of VEGF in core/shell nanofibers and also proved by the expression of α-actinin, myosin
and F-actin marker proteins for vascular tissue engineering.
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